Telegance Consult GmbH
Telefon: 0611 945819 – 0
Telefax: 0611 945819 – 15
Concept and implementation
Telefon: 0228 8865020
Fax: 0228 8865021
cap communications, Gudrun Petersen;
© haitaucher39; vector_master; Tanusha; adamjnorth; lassedesignen; Ben Chams; bloomua; Kasia Bialasiewicz; kalafoto; FotolEdhar – Fotolia.com
Authorised representative according § 6 TDG
Hans-Jörg Guter / President
Peter Schmitz / President
Handelsregister/Amtsgericht Darmstadt HRB 54264
Umsatzsteueridentifikationsnummer DE 204 658 259
Copyright 2013 Telegance Consult GmbH. All content of this Internet site is owned or controlled by Telegance Consult GmbH and is protected by worldwide copyright laws. You may download content only for your personal use for non-commercial purposes but no modification or further reproduction of the content is permitted. The content may otherwise not be copied or used in any way.
The owners of this site will use reasonable efforts to include up-to-date and accurate information in this Internet site, but make no representations, warranties, or assurances as to the accuracy, currency, or completeness of the information provided. The owners of this site shall not be liable for any damages or injury resulting from your access to, or inability to access, this Internet site, or from your reliance on any information provided at this Internet site. This Internet site may provide links or references to other sites but the owners of this site have no responsibility for the content of such other sites and shall not be liable for any damages or injury arising from that content. Any links to other sites are provided as merely a convenience to the users of this Internet site.
This Internet site contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. These statements, at the time they were made, were based on then-current expectations of future events. If any of those underlying assumptions prove or have proven to be inaccurate or unknown or if risks or uncertainties materialize or have materialized, actual results could vary or already may have varied materially from the Company’s expectations and projections in these statements. These risks and uncertainties include general industry conditions and competition; economic conditions, such as interest rate and currency exchange rate fluctuations; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward health care cost containment. The Company assumes no obligation to update any forward-looking statements as a result of new information or future events or developments.